Generation Bio Co

NASDAQ:GBIO   3:59:50 PM EDT
21.43
-0.37 (-1.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Generation Bio Co Stock, NASDAQ:GBIO

301 Binney Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.655.7500
Number of Employees: 100

Description

Generation Bio Co. is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.